Maria Raffaella Barbaro
Overview
Explore the profile of Maria Raffaella Barbaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
811
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbaro M, Bianco F, Cremon C, Marasco G, Bonomini F, Palombo M, et al.
Gut Microbes
. 2025 Jan;
17(1):2452235.
PMID: 39817446
Irritable bowel syndrome (IBS) is a multifactorial condition with heterogeneous pathophysiology, including intestinal permeability alterations. The aim of the present study was to assess the ability of a probiotic blend...
2.
Barbaro M, Cremon C, Marasco G, Savarino E, Guglielmetti S, Bonomini F, et al.
Gastroenterology
. 2024 Jul;
167(6):1152-1166.
PMID: 39004156
Background & Aims: The pathophysiology of irritable bowel syndrome (IBS) is multifactorial and includes epithelial barrier dysfunction, a key element at the interface between the gut lumen and the deeper...
3.
Marasco G, Cremon C, Barbaro M, Bianco F, Stanghellini V, Barbara G
Dig Liver Dis
. 2024 May;
56(12):1971-1979.
PMID: 38772789
Disorders of gut-brain interaction (DGBI) are common chronic conditions characterized by persistent and recurring gastrointestinal symptoms triggered by several pathophysiological factors, including an altered gut microbiota. The most common DGBI...
4.
Marasco G, Cremon C, Barbaro M, Stanghellini V, Barbara G
J Clin Gastroenterol
. 2024 Jan;
58(3):221-231.
PMID: 38227850
Irritable bowel syndrome (IBS) with diarrhea (IBS-D) affects ~1% of the general population and is characterized by abdominal pain associated with diarrhea. IBS-D symptoms significantly impact the quality of life...
5.
Gargari G, Mantegazza G, Cremon C, Taverniti V, Valenza A, Barbaro M, et al.
Gut Microbes
. 2024 Jan;
16(1):2298246.
PMID: 38178601
Probiotics are exploited for adjuvant treatment in IBS, but reliable guidance for selecting the appropriate probiotic to adopt for different forms of IBS is lacking. We aimed to identify markers...
6.
Marasco G, Cremon C, Barbaro M, Stanghellini V, Barbara G
Microbiome Res Rep
. 2023 Dec;
1(2):11.
PMID: 38045643
Irritable bowel syndrome (IBS) affects approximately one tenth of the general population and is characterized by abdominal pain associated with abnormalities in bowel habits. Visceral hypersensitivity, abnormal intestinal motor function,...
7.
Gargari G, Mantegazza G, Taverniti V, Gardana C, Valenza A, Rossignoli F, et al.
Gut Microbes
. 2023 Nov;
15(2):2274128.
PMID: 37910479
The gut microbiota is believed to be a critical factor in the pathogenesis of IBS, and its metabolic byproducts, such as short-chain fatty acids (SCFAs), are known to influence gut...
8.
Marasco G, Visaggi P, Vassallo M, Fiocca M, Cremon C, Barbaro M, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37894846
Eosinophilic gastrointestinal diseases (EGIDs) are an emerging group of pathological entities characterized by an eosinophil-predominant infiltration of different tracts of the gut in the absence of secondary causes of eosinophilia....
9.
Marasco G, Maida M, Cremon C, Barbaro M, Stanghellini V, Barbara G
Aliment Pharmacol Ther
. 2023 Jun;
58(1):128-129.
PMID: 37307549
No abstract available.
10.
Marasco G, Buttitta F, Cremon C, Barbaro M, Stanghellini V, Barbara G
Neurogastroenterol Motil
. 2023 May;
35(12):e14615.
PMID: 37243442
Background: Diverticular disease (DD) is a common condition in Western countries. The role of microbiota in the pathogenesis of DD and its related symptoms has been frequently postulated since most...